Skip to content
Sumitomo Chemical logo

Sumitomo Chemical India

SUMICHEM NSE
₹328.10 No trade today
P/E
28.24
View as Markdown
MCP
Close 4 Nov 2026 ₹328.10 −151.95 −31.7% 1Y
Start ₹480.05

Key Fundamentals

SmallcapFertilizers & AgrochemicalsChemicals

Price-based figures as of · EPS basis: Standalone · TTM

ROCE
23.50%
Debt to Equity
0.02
EPS (TTM)
₹11.62
Book Value
₹74.06
Market Cap
—
P/E (TTM)
28.24
P/B
4.43
ROE
17.60%
Dividend Yield
0.41%
EBITDA
₹818 Cr
52W High
₹572.05
52W Low
₹310.85
Volume
0

Peer Comparison

Commodities › Chemicals › Pesticides & Agrochemicals

Sumitomo Chemical peer comparison
UPL
₹529.0022.09₹43,728 Cr1.281.16%5.64%10.10%₹52,804 Cr₹2,323 Cr
PI Industries
₹2,187.0028.48₹33,248 Cr2.950.69%11.20%15.00%₹6,516 Cr₹1,164 Cr
Sumitomo Chemical (this company)
₹328.1028.24₹15,980 Cr4.430.41%17.60%23.50%₹3,192 Cr₹581 Cr
Bayer CropScience
₹3,249.9019.95₹14,602 Cr4.924.57%23.70%29.10%₹5,595 Cr₹733 Cr
Sharda Cropchem
₹677.959.77₹6,015 Cr1.882.23%23.20%30.20%₹5,357 Cr₹626 Cr
Dhanuka Agritech
₹942.7515.83₹4,217 Cr2.500.21%18.50%23.80%₹1,953 Cr₹268 Cr
Rallis
₹189.6717.23₹3,734 Cr1.681.58%10.20%14.10%₹2,962 Cr₹214 Cr
Median 7 companies₹677.9519.95₹14,602 Cr2.501.16%17.60%23.50%₹5,357 Cr₹626 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

49 Average

Data confidence 100/100

Category scores

Quality
66
Good
Returns, margins, earnings quality 22% weight
Valuation
41
Weak
Cheap vs sector & own history 24% weight
Growth
13
Poor
Sales & profit trajectory 9% weight
Financial Health
89
Strong
Solvency, leverage, coverage 9% weight
Momentum
8
Poor
Trend strength, vol-adjusted 12% weight
Ownership
56
Good
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

2
  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 34.5%

Weaknesses

1
  • The company has delivered a poor sales growth of 3.81% over past five years.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1324
OscillatorsBullish324
Moving AveragesStrong Bearish1000

Key readings

RSI (14)
24.88
Bullish
MACD (12,26,9)
−33.60
Bearish
SMA (50)
432.88
Bearish
SMA (200)
448.00
Bearish

As of

Analyst Rating

Based on 9 analysts
BUY89%

8 of 9 analysts rate Buy, 1 Hold, 0 Sell.

As of

BUY
8
89%
HOLD
1
11%
SELL
0
0%

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y+15.97%
5Y+3.81%
3Y−3.19%
1Y+3.11%
TTM−3.48%

Net profit

Net profit growth by window
10Y+23.65%
5Y+9.50%
3Y+2.58%
1Y+8.17%
TTM+5.06%

Operating cash flow

Operating cash flow growth by window
10Y+23.89%
5Y+0.88%
3Y+4.43%
1Y−3.28%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y+8.61 pp
5Y+2.44 pp
3Y+1.87 pp
1Y+0.74 pp
TTM+0.77 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹799 Cr
Mar 2018₹1,911 Cr
Mar 2019₹2,223 Cr
Mar 2020₹2,423 Cr
Mar 2021₹2,643 Cr
Mar 2022₹3,060 Cr
Mar 2023₹3,511 Cr
Mar 2024₹2,833 Cr
Mar 2025₹3,090 Cr
Mar 2026₹3,186 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹62.00 Cr
Mar 2018₹145 Cr
Mar 2019₹167 Cr
Mar 2020₹206 Cr
Mar 2021₹345 Cr
Mar 2022₹434 Cr
Mar 2023₹503 Cr
Mar 2024₹370 Cr
Mar 2025₹502 Cr
Mar 2026₹543 Cr

Analyst Forecasts

Forecast For
FY27 consensus · EBITDA
₹686 Cr −16.2% vs FY26
Reported High Mean Low

AI Analysis — Bull vs Bear

Figures as of 30 Oct 2026
AI opinion · based on fundamentals
Risk medium

Sumitomo Chemical India trades at ₹315.1 as of 2026-10-30 with a market cap of ₹15,728 Cr, a PE of 27.12x, and ROE of 16%. The stock sits near its 52-week low of ₹310.85, having declined 45% from its 52-week high of ₹572.05, while the company remains virtually debt-free with a debt-to-equity ratio of 0.02.

Bull Case 8
  • Near-zero leverage with a debt-to-equity ratio of just 0.02, giving the company significant financial flexibility and resilience through cyclical downturns
  • ROCE of 20.98% indicates efficient capital deployment and strong underlying business economics despite recent revenue headwinds
  • Consistent long-term ROE track record — 20% over both 5-year and 10-year periods — reflects durable competitive advantages in its product portfolio
  • Compounded profit growth of 24% over 10 years and 10% over 5 years demonstrates an ability to grow earnings meaningfully over longer horizons
  • Healthy dividend payout ratio of 34.5% with a current yield of 0.39%, showing commitment to returning capital to shareholders even during a softer period
  • Trading near its 52-week low of ₹310.85 (current price ₹315.1), representing a 45% correction from the 52-week high of ₹572.05, which compresses valuations relative to recent history
  • Compounded sales growth of 16% over 10 years shows the company has scaled meaningfully over the longer term, supported by India's growing agrochemical demand
  • TTM EPS of ₹11.62 with 3% TTM profit growth suggests earnings have stabilised and are no longer declining
Bear Case 7
  • Compounded sales growth has turned negative at -3% on both a TTM and 3-year basis, signalling sustained top-line contraction rather than a one-off dip
  • Stock price CAGR of -23% over 1 year and -2% over 3 years indicates persistent value erosion for shareholders with no recovery trend visible
  • 5-year compounded sales growth of just 4% (reported as 3.81%) is significantly below the 10-year average of 16%, pointing to a structural slowdown in revenue momentum
  • PE of 27.12x on TTM EPS of ₹11.62 remains elevated for a company delivering negative sales growth, suggesting the stock may not yet reflect the earnings slowdown adequately
  • Current ROE of 16% has declined from the 5-year average of 20% and the last-year figure of 18%, indicating a downward trend in return on equity
  • 5-year stock CAGR of 0% means the stock has generated zero capital appreciation over half a decade, underperforming broad market indices significantly
  • Dividend yield of only 0.39% provides minimal income cushion for investors enduring the ongoing price correction

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

12h ago

TL;DR: Sumitomo Chemical India faces a challenging quarter with Q2FY27 showing broad-based weakness across revenue, profitability, and margins. The 297 bps EBITDA margin compression is notable and suggests either input cost pressures or weaker product mix. The global parent's earnings decline adds a layer of concern around group-level support and demand outlook. The trend is deteriorating, and investors should watch for signs of margin recovery and volume growth in upcoming quarters.

Headwinds 3
  • Q2 net profit falls 11% YoY Nov 02

    Sumitomo Chemical India reported Q2FY27 net profit of ₹157.4 crore, down 11% YoY, with revenue declining 2% YoY to ₹907.3 crore.

  • EBITDA margin compresses 297 bps Nov 02

    EBITDA margin contracted by 297 basis points YoY to 20.5% in Q2FY27, signaling pressure on operating profitability.

  • Global parent EPS declines Nov 02

    The global parent entity's EPS dropped 5.88% to $0.80, indicating broader weakness across the Sumitomo Chemical group.

Quarterly Results

₹ Cr
SUMICHEM quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales
724
903
540
664
832
971
622
665
1,048
914
552
671
1,054
891
Expenses
643
715
474
526
670
729
521
548
828
697
456
539
819
708
Operating Profit
81
188
66
139
162
242
101
117
220
217
96
133
235
183
OPM %
11%
21%
12%
21%
19%
25%
16%
18%
21%
24%
17%
20%
22%
21%
Other Income
18
25
27
27
26
31
31
31
39
39
22
32
74
43
Interest
1
1
1
1
1
1
1
1
1
2
2
2
2
2
Depreciation
14
16
16
16
14
15
18
16
15
16
16
16
16
16
PBT
83
196
76
149
173
257
113
132
242
238
100
147
291
209
Tax %
26%
27%
27%
26%
26%
26%
25%
25%
26%
25%
25%
25%
26%
25%
Net Profit
62
144
55
109
128
191
84
98
180
178
75
111
217
156
EPS (₹)
1.24
2.88
1.1
2.19
2.57
3.82
1.69
1.97
3.6
3.56
1.5
2.22
4.34
—

Sep 2026: from the results filed on 26 Oct 2026, ahead of the full statement, so some rows are blank.

Profit & Loss

₹ Cr
SUMICHEM profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
671
724
799
1,911
2,223
2,423
2,643
3,060
3,511
2,833
3,090
3,186
3,192
Expenses
614
635
698
1,691
1,932
2,088
2,155
2,458
2,843
2,358
2,467
2,520
2,511
Operating Profit
57
89
101
219
291
335
488
603
668
474
623
666
680
OPM %
8%
12%
13%
11%
13%
14%
18%
20%
19%
17%
20%
21%
21%
Other Income
8
26
10
31
0
−20
19
36
45
96
119
131
166
Interest
1
1
1
5
5
7
7
8
6
5
6
7
7
Depreciation
6
7
7
24
28
41
47
45
52
61
63
63
64
PBT
58
107
103
221
258
267
453
586
655
503
674
727
776
Tax %
40%
40%
40%
34%
35%
23%
24%
26%
23%
27%
26%
25%
—
Net Profit
35
65
62
145
167
206
345
434
503
370
502
543
580
EPS (₹)
—
—
—
—
—
4.12
6.92
8.69
10.09
7.41
10.06
10.88
11.62
Div. Payout %
0%
0%
0%
0%
38%
18%
12%
12%
12%
80%
12%
12%
—

Balance Sheet

₹ Cr
SUMICHEM balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
233
233
275
275
275
499
499
499
499
499
499
499
Reserves
−2
63
360
665
761
710
1,029
1,425
1,881
1,941
2,397
2,885
Borrowings
0
0
0
10
20
36
33
38
34
25
45
53
Other Liabilities
234
280
288
695
791
848
1,097
1,047
955
822
988
997
Total Liabilities
466
576
922
1,644
1,846
2,093
2,658
3,009
3,368
3,287
3,930
4,434
Fixed Assets
51
52
53
267
279
319
309
390
430
489
482
499
CWIP
0
1
7
9
8
10
14
35
71
23
28
20
Investments
0
0
277
2
1
87
291
357
239
425
601
1,226
Other Assets
415
523
585
1,367
1,558
1,676
2,043
2,227
2,628
2,351
2,819
2,690
Total Assets
466
576
922
1,644
1,846
2,093
2,658
3,009
3,368
3,287
3,930
4,434

Cash Flow

₹ Cr
SUMICHEM cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
4
52
−21
49
75
222
424
223
389
756
458
443
Investing
−8
−5
−289
−40
−35
−118
−282
−281
−327
−426
−405
−329
Financing
0
0
276
7
−65
−61
−47
−63
−73
−331
−65
−81
Net Cash Flow
−4
47
−34
16
−26
43
95
−120
−10
−1
−11
33
Free Cash Flow
−6
44
−310
6
36
184
382
111
270
695
431
404
CFO/OP
44
102
14
60
56
90
109
61
83
187
100
91

Ratios

SUMICHEM financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
83
92
101
105
110
128
117
101
98
91
90
81
Inventory Days
135
169
191
202
193
133
185
198
157
135
154
166
Days Payable
109
132
115
176
136
112
145
110
87
96
107
86
Cash Conversion Cycle
109
130
177
131
167
150
157
189
168
131
136
161
Working Capital Days
69
79
113
113
116
109
95
127
136
173
183
155
ROCE %
27%
41%
22%
29%
27%
26%
33%
34%
30%
21%
25%
23%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Sumitomo Chemical insights

60 extracted metrics across FY11–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 75.00%
  • DIIs 9.69%
  • Public 8.99%
  • Others 3.43%
  • FIIs 2.89%

No promoter shares pledged as of 14 Oct 2026

Change since Jun 2026

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

  • Q1 FY27 concall · Jul 2026
    PPT
  • Q4 FY26 concall · Jun 2026
    Transcript PPT
  • Q4 FY26 concall · May 2026
    PPT
  • Q3 FY26 concall · Jan 2026
    PPT
  • Q3 FY26 concall · Jan 2026
    PPT

Frequently Asked Questions about Sumitomo Chemical India

What does Sumitomo Chemical India Ltd do?
Sumitomo Chemical India Ltd. (SCIL) is one of the leading players in the industry which has a balanced portfolio of technical as well as formulation products along with backward integration for some products.
Where is Sumitomo Chemical India Ltd (SUMICHEM) listed?
Sumitomo Chemical India Ltd trades as SUMICHEM on the NSE and under code 542920 on the BSE.
Which sector does Sumitomo Chemical India Ltd belong to?
Sumitomo Chemical India Ltd is classified under the Chemicals sector, in the Pesticides & Agrochemicals industry.
What is the PE ratio of Sumitomo Chemical India Ltd?
Sumitomo Chemical India Ltd trades at a PE ratio of 28.24 as of 4 Nov 2026, on earnings per share of ₹11.62, against a book value of ₹74.06 per share.
What is the 52-week high and low of Sumitomo Chemical India Ltd?
Over the last 52 weeks Sumitomo Chemical India Ltd has traded between ₹310.85 and ₹572.05 as of 4 Nov 2026.
Does Sumitomo Chemical India Ltd pay dividends?
Sumitomo Chemical India Ltd has a dividend yield of 0.41%.
What is the Return on Equity (ROE) of Sumitomo Chemical India Ltd?
Sumitomo Chemical India Ltd reported a return on equity of 17.60%. Its debt-to-equity ratio is 0.02.

Company Information

Sumitomo Chemical India Ltd. (SCIL) is one of the leading players in the industry which has a balanced portfolio of technical as well as formulation products along with backward integration for some products. The Company is known for domestic marketing of proprietary products of its Japanese parent -Sumitomo Chemical Company Limited in agrochemicals, animal nutrition, and environmental health business segments. With the integration of Excel Crop Care Limited, the Company now has a strong portfolio of generics in addition to specialty products and a strong combined marketing network. With this integration, the Company has moved up several notches in the pecking order of the Indian crop protection industry. SCIL has also marked its presence in Africa and several other geographies of the world.

Website sumichem.co.in
CEO Mr. Chetan Shantilal Shah
Employees 1,646
Listed 27 Jan 2020
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SUMICHEM.md for Sumitomo Chemical India Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Fertilizer & Agrochemical stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month